From Big Data to Better Drugs: How AI-Driven Platforms Are Changing Cancer Research
Cancer research often relies on massive and complex datasets, which can take time and effort to sift through manually. The proprietary PDAOAI platform from Oncotelic Therapeutics helps with this problem as it was designed to analyze large biomedical datasets to extract meaningful signals and help researchers. The company has also curated a detailed TGF-β literature corpus containing 125,000+ PubMed abstracts that represents all of the scientific knowledge related to TGF-β. This has now expanded to >20M abstracts representing the totality of scientific literature. Cancer research is crucial for understanding, diagnosing, treating, and preventing the disease. However, this research often relies…